Reactions to the New DMAA Outcomes Guidelines
September 14, 2006
What You'll Learn
DMAA just released the much awaited DMAA Outcomes Guidelines Report. The DMAA guidelines are the result of a year-long initiative to develop industry consensus on the much-debated, often controversial methods used in measuring disease management outcomes.
Solucia has assembled a panel of industry experts to address the impact of the DMAA Outcomes Guidelines Report on the practice of outcomes analysis. Questions to be addressed include: What are DMAA's key recommendations for financial outcomes measurement? How do the proposed guidelines address well-known measurement issues such as regression to the mean and other biases? How can a purchaser evaluate outcomes using the DMAA guidelines? How successful will the guidelines be in convincing program purchasers?
Our Speakers
Ariel Linden, DrPH, MS
President, Linden Consulting Group
Dr. Linden began his healthcare career as a clinical scientist in cardiovascular and pulmonary physiology. Since completing his doctorate at UCLA in health service research, Dr. Linden has worked at various health plans in the area of clinical quality improvement and research. His focus in the last three years has been on Disease Management, specifically evaluation strategies for determining program effectiveness. In this area alone, Dr. Linden has recently published numerous peer-reviewed papers, letters to the editors and a book chapter. In 2003 he was commissioned to write a position paper for the industry’s trade association-the Disease Management Association (DMAA).
Dr. Linden is active in the Managed Care accreditation process, serving as a surveyor for the Accreditation Association of Ambulatory Health Care (AAAHC). Additionally, he sits on several nationwide boards and committees focused on improving the quality of care delivered to patients, health plan members, and disease management program participants.
Dr. Linden currently holds adjunct positions at Oregon Health and Science University’s School of Medicine and School of Nursing.
Ian Duncan, FSA MAAA
President, Solucia Inc.
Ian Duncan has thirty years of experience in the healthcare actuarial field. Between 2000 and 2002 was General Manager of a start-up provider of predictive modeling and other services to the Disease Management industry. Clients included United Healthcare, HealthNet of Arizona, Lifeguard and M-Plan. Currently he consults to vendors and purchasers of DM services, health plans, predictive modeling companies and reinsurers who are seeking a financial return for their Medical Management programs.
Al Lewis
President of the Disease Management Purchasing Consortium International, Inc.
Al Lewis is the founder and President of the Disease Management Purchasing Consortium International, Inc. DMPC is the leading consultant/procurement broker in the field of disease management. In total, programs initiated by DMPC member payors account for the majority of all Americans enrolled in full-risk outsourced disease management programs today by states and health plans as well as several large employers, and roughly 50% of all competitive health plan bids by dollar volume. The 98 current DMPC members cover 80-million lives. DMPC has been the subject of a cover story in Managed Healthcare Executive, and has been profiled in Demand and Disease Management, Managed Care, Healthcare Benchmarking, Healthplan, HealthLeaders, and Employee Benefit News.
He is founder and past president of the Disease Management Association of America, the official industry association. He was voted Best Speaker and Most Influential person in a poll by Computer Sciences Corp., and is one of only two two-time winners (1999, 2004) of the DMAA’s Karen Coughlin Award for Outstanding Achievement in Disease Management. Al holds undergraduate and law degrees from Harvard University, Phi Beta Kappa and holds a Visiting Scholar appointment at the Heller School for Social Policy, Brandeis University.
Gordon Norman, MD, MBA
Executive Vice President and Chief Medical Officer, Alere Medical, Inc.
Leader of Financial Metrics Group- DMAA Outcomes Steering Committee
2007 Chair of DMAA Quality & Research Committee
The Details
Date: Wednesday, January 24, 2007
Time: 1:00 to 2:30 p.m. Eastern Time
Location: Wherever you are. We will provide dial-in and logon instructions via email to registrants in advance of the session.
Cost: Registration Fee is $295. Your registration fee entitles you to one phone line into the conference. Feel free to use a speakerphone and invite your colleagues to attend.
BONUS!! All paid participants who register by January 15 will receive a complimentary copy of the DMAA Outcomes Guidelines. It is included in the registration fee. Your copy of the Guidelines will be shipped prior to the Webcast.
CD-ROM: CD-ROM Recording of the session will be available after completion of the webcast. Price: $75 for registrants and $125 for non-registrants.
If you have any questions, please email us at info@soluciaconsulting.com or call 860-676-8808.
